Category
**CE credits for webinar recordings are available for 2 years from the original live presentation date of the webinar**
Missed Safety Opportunities with Subcutaneous Insulin: Addressing the Often Unknown Safety Challenges with Insulin
Item Details
Missed Safety Opportunities with Subcutaneous Insulin: Addressing the Often Unknown Safety Challenges with Insulin
Item Name:
Missed Safety Opportunities with Subcutaneous Insulin: Addressing the Often Unknown Safety Challenges with Insulin
Item #:
100097WBCD
Price/ea:
$215.00

Product Image Gallery:

Missed Safety Opportunities with Subcutaneous Insulin: Addressing the Often Unknown Safety Challenges with Insulin

Program Overview:

Clearly, safe and effective control of blood glucose levels with insulin is essential in the management of hyperglycemia. According to recently released 2014 American Diabetes Association (ADA) guidelines, non-critically ill, hospitalized diabetic patients should be managed with scheduled subcutaneous insulin doses that include basal, nutritional, and correctional components as the preferred method for achieving and maintaining glucose control. A 2014 survey by the Institute for Safe Medication Practice (ISMP) suggests that pharmacists and nurses believe hospitalized patients are more vulnerable to errors with subcutaneous insulin than with any other high-alert drug, and that more must be done to prevent patient harm with this high-alert medication.

Join our faculty as they discuss current ADA guidelines for standardizing basal/bolus insulin doses and the clinical significance for optimal glycemic control. Learn about the often overlooked risk associated with the prescribing, administration and monitoring of subcutaneous insulin therapy, including the continued misuse of sliding-scale insulin orders, as well as the continued challenges with patient assessment, education, and compliance. Once identified, we are confident that practitioners can play a significant role in managing the risks associated with subcutaneous insulin use. The opportunity for enhancing the safety of subcutaneous insulin here- Let's not miss it!

 

Intended Audience: 
Interdisciplinary teams are encouraged to attend together:

  • Hospital and Health System Leadership
  • Quality and Risk Management Leaders
  • Physician, Pharmacy, and Nursing Leaders
  • Patient and Medication Safety Officers
  • Frontline Practitioners, including prescribers, nurses and pharmacists
  • Diabetic Educators
  • Ambulatory Clinic Directors and Staff who care for diabetic patients
  • Insulin ADE teams

Objectives:
Following completion of the webinar, participants will be able to:

  • Discuss the current ADA guidelines for standardizing basal/bolus insulin doses and the clinical significance for optimal glycemic control
  • List the ever-changing challenges in prescribing, administering and monitoring subcutaneous insulin
  • Discuss the often overlooked best practices for the use of subcutaneous insulin in hospitalized patients
  • Select at least one strategy to improve the process of insulin management for inpatient care

Speakers: 
Susan Cornell, BS, PharmD, CDE, FAPhA, FAADE
Assistant Director of Experiential Education
Associate Professor of Pharmacy Practice
Midwestern University Chicago College of Pharmacy
Downers Grove, IL

Matthew Grissinger, RPh, FISMP, FASCP
Director of Error Reporting Programs
Institute for Safe Medication Practices 
Horsham, PA


Moderator:
Matthew Grissinger, RPh, FISMP, FASCP
Director of Reporting Programs
Institute for Safe Medication Practices
Horsham, PA


CONTINUING EDUCATION:
This webinar is approved for 1.5 hours of Pharmacy Continuing Education and 1.0 hours of Nursing Continuing Education. There is no additional charge for the continuing education credits for this webinar.

Educational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmaceutical education. This program is approved for 1.5 hours (0.15 CEUs). Educational Review Systems is also approved for pharmacy continuing education by the state of Florida. 

Live Continuing Education Credits must be completed by 8/30/2015. We are unable to process the request after this date. 
Enduring Continuing Education Credits will expire on 7/30/2017 but must be completed within 30 days of the date you watched the program. We are unable to process the request after this date.

Quantity:
 
ISMP RETURN POLICY

You may return most items sold by ISMP within 30 days of shipping for a refund less the cost of shipping and handling.  We do not charge a restocking fee.  All refunds will be made in the form of a check regardless of the original form of payment. We cannot accept returns on our videos "Building System Safeguards for the Safe Use of High-Alert Medications", "Patient Safety Requires a Team Effort", "Patients Play a Vital Role in Patient Safety", "Medical Leaders in Patient Safety", or any item that is not returned in its original condition, is damaged, or is missing parts.

CD- "Missed Safety Opportunities with Subcutaneous Insulin: Addressing the Often Unknown Safety Challenges with Insulin" (7/30/2015)
Powered by PDshop & Asp.Net
ASP.NET Shopping Cart Software